What is Cardinal Health's market cap?

Cardinal Health (CAH) has a market capitalization of $55.5B and trades on NYSE.

What is Cardinal Health's revenue and profitability?

Cardinal Health generated $250.74B in trailing twelve-month revenue with net income of $1.6B, representing a net margin of 0.6%. Gross margin stands at 3.8%, with free cash flow of $4.4B. These figures are based on the Q1 2026 filing.

Who are Cardinal Health's competitors?

Cardinal Health's key competitors include McKesson Corporation, Cencora, Inc., BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Cardinal Health partner with?

Cardinal Health's notable partners include CVS Health Corporation, Vizient, Inc., Premier, Inc., and others.

What subsidiaries does Cardinal Health have?

Cardinal Health's subsidiaries include Advanced Diabetes Supply Group, GI Alliance, Integrated Oncology Network, and others.

Where is Cardinal Health headquartered?

Cardinal Health is headquartered in United States of America and employs approximately 48,000 people. It has been publicly traded since 1983.

Cardinal Health

CAH

Cardinal Health is a global healthcare services and products company that serves as a critical link in the medical supply chain.

Market cap

$55.54B+41.1%

Revenue$250.74B+12.8%

Net income$1.6B-0.1%

Free cash flow$4.4B+78.9%

EPS (diluted)$6.55+2.3%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q3 2026 report

April 30, 2026

Revenue$60.9BMiss by $1.2B EPS$3.17Beat by $0.38

Read the full report

Next report

Aug 11, 2026 (in a month)

Revenue estimate$65.0B

EPS estimate$2.41

Financials

Q3 2026

Income statement

See full

Revenue$60.9B+11.0%

Gross profit$2.5B+17.7%

Operating income$509.0M-30.3%

Net income$399.0M-21.1%

EPS (diluted)$1.69-19.5%

Balance sheet

See full

Cash & equivalents$3.9B+18.4%

Total debt$8.9B+16.1%

Total equity-$2.8B+3.9%

Total assets$56.7B+13.7%

Cash flow

See full

Operating cash flow$1.8B-37.6%

CapEx$146.0M+15.9%

Free cash flow$1.7B-40.0%

Valuation & ratios

Valuation

See full

Market cap$55.54B+41.1%

Enterprise value$60.52B+34.4%

P/E35.7×+10.5×

P/S0.2×0.0×

Profitability

See full

Gross margin3.8%+0.2pp

Operating margin0.9%-0.1pp

Net margin0.6%-0.1pp

FCF margin1.7%+0.6pp

Returns & leverage

See full

Current ratio0.9×0.0×

Segments

By segment

See full

Pharmaceutical and Specialty Solutions$56.1B+11.3%

Cost of product sold$3.1B-0.4%

Other Segments$1.7B+30.8%

Competitors

By market cap

McKesson$95.8B+6.7%

Cencora$60.2B—

Cardinal Health$55.5B+41.1%

Medline, Inc. $34.1B—

BrightSpring Health Services, Inc.$13.8B+256%

Henry Schein$9.5B+1.6%

Cumberland Pharmaceuticals$93.6M+98.7%

Cosmos Holdings Inc.$16.4M+32.1%

By revenue growth

BrightSpring Health Services, Inc.+28.0%

Cardinal Health+12.8%

Cumberland Pharmaceuticals+2.1%

By net margin

Medline, Inc. 4.62%-0.7pp

Henry Schein2.95%-0.3pp

BrightSpring Health Services, Inc.2.27%+2.3pp

McKesson1.18%+0.3pp

Cardinal Health0.62%-0.1pp

Cencora0.599%+0.6pp

Cumberland Pharmaceuticals-17.6%-9.6pp

Profile

Cardinal Health is a global healthcare services and products company that serves as a critical link in the medical supply chain. The company specializes in the distribution of pharmaceuticals and medical products while also manufacturing its own line of surgical and laboratory supplies. Its value proposition centers on enhancing supply chain efficiency and providing customized solutions for hospitals, pharmacies, and patients in the home.

Competitive position

A leading global distributor of pharmaceuticals and medical products with a significant manufacturing presence in surgical and laboratory supplies.

GeographiesUnited States, Canada, Europe, Asia

Customer segmentsHospitals, Retail Pharmacies, Physician Practices, Home Healthcare

Business modelWholesale Distribution, Manufacturing, Managed Service Organization (MSO), Direct-to-Consumer (DTC)

SuppliersBranded pharmaceutical manufacturers, Generic drug manufacturers, Raw material suppliers for medical devices, Third-party logistics providers

CustomersRetail pharmacy chains, Independent drug stores, Hospital systems, Ambulatory surgery centers, Chronic care patients

CountryUnited States of America

Listed1983

Employees48.0K

CEOJason Hollar

SectorHealthcare

IndustryMedical - Distribution

Websitecardinalhealth.com

FilingsSEC EDGAR

Ask your AI about Cardinal Health.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cardinal Health's market cap?: Cardinal Health (CAH) has a market capitalization of $55.5B and trades on NYSE.
What is Cardinal Health's revenue and profitability?: Cardinal Health generated $250.74B in trailing twelve-month revenue with net income of $1.6B, representing a net margin of 0.6%. Gross margin stands at 3.8%, with free cash flow of $4.4B. These figures are based on the Q1 2026 filing.
Who are Cardinal Health's competitors?: Cardinal Health's key competitors include McKesson Corporation, Cencora, Inc., BrightSpring Health Services, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Cardinal Health partner with?: Cardinal Health's notable partners include CVS Health Corporation, Vizient, Inc., Premier, Inc., and others.
What subsidiaries does Cardinal Health have?: Cardinal Health's subsidiaries include Advanced Diabetes Supply Group, GI Alliance, Integrated Oncology Network, and others.
Where is Cardinal Health headquartered?: Cardinal Health is headquartered in United States of America and employs approximately 48,000 people. It has been publicly traded since 1983.